Bathi operasional sadurunge amortisasi: PolyPid Ltd. (PYPD)
PolyPid Ltd. (PYPD) minimizes surgical risks by developing long-acting agents for patient protection. Operating income dynamics confirm this trajectory, where 0.00 determines the current value of the metric. Expenses for the final stages of gel testing are covered by external capital. Automated Israeli plants and reserves of rare polymers guarantee production stability.
%20Bathi%20operasional%20EBITDA&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_PYPD_-_PolyPid-Ltd._-_Operating-profit-EBITDA "PolyPid - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi PYPD (periode 23.11.2025 - 10.11.2026) | 👁️GURU.Markets👁️")
PolyPid - rincian analitis lan metrik utama (PYPD)
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- indikator nilai aset resik miturut neraca:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas PolyPid Ltd.|PYPD - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal PolyPid Ltd|PYPD - Gunggung utang perusahaan|Utang-utang marang aset resik PolyPid|PYPD - Utang jangka dawa perusahaan|Utang jangka cendhak PolyPid|Rasio likuiditas darurat polypid.com
- informasi bathi lan kelipatan valuasi:
PYPD - Bathi resik perusahaan|Prakiraan bathi perusahaan PolyPid Ltd.|PYPD - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake PolyPid Ltd|PYPD - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PolyPid|PYPD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan PolyPid|PYPD - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan polypid.com|PYPD - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PolyPid Ltd.
Ringkesan analitik perusahaan:PYPD PolyPid Ltd.
To minimize investment risks, it is critical to track actual cash flow before debt payments and tax obligations. Amid stable demand for the biotechnologies of PolyPid Ltd. (PYPD), the company's operating profit confirms the business's resilience to macroeconomic shocks. The growth of this indicator reflects high asset liquidity and the issuer's ability to generate cash.
Pesaing PolyPid Ltd. (PYPD)
Pendapatan operasional sadurunge ngurangi amortisasi Summit Pharma (SMMT)|MRNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PCVX (vaxcyte.com) - Bathi operasional sadurunge amortisasi|TARS: Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi CRMD (CorMedix Inc)|MCRB (Seres) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Spero Pharma SPRO|Bathi operasional EBITDA SCYX|Bathi operasional sadurunge ngurangi amortisasi an2therapeutics.com ANTX|LakeShore Biopharma - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ITRM (Iterum Therapeutics PLC)|BiomX Ltd - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Soligenix, Inc. SNGX|60degreespharma.com (SXTP) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi oragenics.com (OGEN)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OpGen
